Doctor Marc Evans

Cardiff (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

Risk of stroke in patients with type 2 diabetes receiving semaglutide or a dipeptidyl peptidase-4 inhibitor: a real-world US claims database analysis

Presentation

Risk of stroke in patients with type 2 diabetes receiving semaglutide or a dipeptidyl peptidase-4 inhibitor: a real-world US claims database analysis

ESC 365 is supported by

novartis

Explore sponsored resources